{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:43:22Z","timestamp":1783691002674,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["16K09865"],"award-info":[{"award-number":["16K09865"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Cancer Center Research and Development Fund","award":["26-A-4"],"award-info":[{"award-number":["26-A-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00277-019-03671-5","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T23:02:22Z","timestamp":1553814142000},"page":"1675-1687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mucosa-associated lymphoid tissue lymphoma with t(11;18)(q21;q21) translocation: long-term follow-up results"],"prefix":"10.1007","volume":"98","author":[{"given":"Kosuke","family":"Toyoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko Miyagi","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayako","family":"Yuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Makita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Munakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Tobinai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-7865","authenticated-orcid":false,"given":"Yukio","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"issue":"17","key":"3671_CR1","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","volume":"127","author":"E Zucca","year":"2016","unstructured":"Zucca E, Bertoni F (2016) The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood 127(17):2082\u20132092. \n                    https:\/\/doi.org\/10.1182\/blood-2015-12-624304","journal-title":"Blood"},{"issue":"2","key":"3671_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21330","volume":"66","author":"M Raderer","year":"2016","unstructured":"Raderer M, Kiesewetter B, Ferreri AJ (2016) Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin 66(2):153\u2013171. \n                    https:\/\/doi.org\/10.3322\/caac.21330","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"3671_CR3","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","volume":"15","author":"C Thieblemont","year":"1997","unstructured":"Thieblemont C, Bastion Y, Berger F, Rieux C, Salles G, Dumontet C, Felman P, Coiffier B (1997) Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15(4):1624\u20131630","journal-title":"J Clin Oncol"},{"issue":"10","key":"3671_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1023\/A:1008202303666","volume":"8","author":"IA Auer","year":"1997","unstructured":"Auer IA, Gascoyne RD, Connors JM, Cotter FE, Greiner TC, Sanger WG, Horsman DE (1997) t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 8(10):979\u2013985","journal-title":"Ann Oncol"},{"issue":"10","key":"3671_CR5","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","volume":"18","author":"B Streubel","year":"2004","unstructured":"Streubel B, Simonitsch-Klupp I, Mullauer L, Lamprecht A, Huber D, Siebert R, Stolte M, Trautinger F, Lukas J, Puspok A, Formanek M, Assanasen T, Muller-Hermelink HK, Cerroni L, Raderer M, Chott A (2004) Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 18(10):1722\u20131726. \n                    https:\/\/doi.org\/10.1038\/sj.leu.2403501","journal-title":"Leukemia"},{"issue":"11","key":"3671_CR6","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1182\/blood.V93.11.3601","volume":"93","author":"J Dierlamm","year":"1999","unstructured":"Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez JM, Hossfeld DK, De Wolf-Peeters C, Hagemeijer A, Van den Berghe H, Marynen P (1999) The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 93(11):3601\u20133609","journal-title":"Blood"},{"issue":"42","key":"3671_CR7","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1038\/sj.onc.1203018","volume":"18","author":"T Akagi","year":"1999","unstructured":"Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, Ota H, Nakamura S, Morishima Y, Taniwaki M, Seto M (1999) A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 18(42):5785\u20135794","journal-title":"Oncogene"},{"issue":"24","key":"3671_CR8","first-page":"6205","volume":"59","author":"JA Morgan","year":"1999","unstructured":"Morgan JA, Yin Y, Borowsky AD, Kuo F, Nourmand N, Koontz JI, Reynolds C, Soreng L, Griffin CA, Graeme-Cook F, Harris NL, Weisenburger D, Pinkus GS, Fletcher JA, Sklar J (1999) Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res 59(24):6205\u20136213","journal-title":"Cancer Res"},{"issue":"5","key":"3671_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2005.04.012","volume":"7","author":"H Zhou","year":"2005","unstructured":"Zhou H, Du MQ, Dixit VM (2005) Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 7(5):425\u2013431. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2005.04.012","journal-title":"Cancer Cell"},{"issue":"38","key":"3671_CR10","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.1038\/sj.onc.1210342","volume":"26","author":"PC Lucas","year":"2007","unstructured":"Lucas PC, Kuffa P, Gu S, Kohrt D, Kim DS, Siu K, Jin X, Swenson J, McAllister-Lucas LM (2007) A dual role for the API2 moiety in API2-MALT1-dependent NF-kappaB activation: heterotypic oligomerization and TRAF2 recruitment. Oncogene 26(38):5643\u20135654. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1210342","journal-title":"Oncogene"},{"issue":"6016","key":"3671_CR11","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1198946","volume":"331","author":"S Rosebeck","year":"2011","unstructured":"Rosebeck S, Madden L, Jin X, Gu S, Apel IJ, Appert A, Hamoudi RA, Noels H, Sagaert X, Van Loo P, Baens M, Du MQ, Lucas PC, McAllister-Lucas LM (2011) Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation. Science 331(6016):468\u2013472. \n                    https:\/\/doi.org\/10.1126\/science.1198946","journal-title":"Science"},{"issue":"19","key":"3671_CR12","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1038\/onc.2013.195","volume":"33","author":"S Rosebeck","year":"2014","unstructured":"Rosebeck S, Rehman AO, Apel IJ, Kohrt D, Appert A, O'Donnell MA, Ting AT, Du MQ, Baens M, Lucas PC, McAllister-Lucas LM (2014) The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-kappaB signaling. Oncogene 33(19):2520\u20132530. \n                    https:\/\/doi.org\/10.1038\/onc.2013.195","journal-title":"Oncogene"},{"key":"3671_CR13","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.1038\/ncomms6908","volume":"6","author":"Z Nie","year":"2015","unstructured":"Nie Z, Du MQ, McAllister-Lucas LM, Lucas PC, Bailey NG, Hogaboam CM, Lim MS, Elenitoba-Johnson KS (2015) Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma. Nat Commun 6:5908. \n                    https:\/\/doi.org\/10.1038\/ncomms6908","journal-title":"Nat Commun"},{"issue":"1","key":"3671_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4331\/wjbc.v7.i1.128","volume":"7","author":"S Rosebeck","year":"2016","unstructured":"Rosebeck S, Lim MS, Elenitoba-Johnson KS, McAllister-Lucas LM, Lucas PC (2016) API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis. World J Biol Chem 7(1):128\u2013137. \n                    https:\/\/doi.org\/10.4331\/wjbc.v7.i1.128","journal-title":"World J Biol Chem"},{"issue":"4","key":"3671_CR15","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1182\/blood.V98.4.1182","volume":"98","author":"H Liu","year":"2001","unstructured":"Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG, Du MQ (2001) T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood 98(4):1182\u20131187","journal-title":"Blood"},{"issue":"9249","key":"3671_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","volume":"357","author":"H Liu","year":"2001","unstructured":"Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi RA, Diss TC, Dogan A, Megraud F, Rambaud JC, Du M-Q, Isaacson PG (2001) Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 357(9249):39\u201340. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(00)03571-6","journal-title":"Lancet"},{"issue":"5","key":"3671_CR17","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1053\/gast.2002.33047","volume":"122","author":"H Liu","year":"2002","unstructured":"Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C, Lavergne A, Boot H, Caletti G, Wundisch T, Molina T, Taal BG, Elena S, Thomas T, Zinzani PL, Neubauer A, Stolte M, Hamoudi RA, Dogan A, Isaacson PG, Du MQ (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122(5):1286\u20131294","journal-title":"Gastroenterology"},{"issue":"4","key":"3671_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00019606-200112000-00001","volume":"10","author":"Y Kobayashi","year":"2001","unstructured":"Kobayashi Y, Nakata M, Maekawa M, Takahashi M, Fujii H, Matsuno Y, Fujishiro M, Ono H, Saito D, Takenaka T, Hirase N, Nishimura J, Akioka T, Enomoto K, Mikuni C, Hishima T, Fukayama M, Sugano K, Hosoda F, Ohki M, Tobinai K (2001) Detection of t(I 1; 18) in MALT-type lymphoma with dual-color fluorescence in situ hybridization and reverse transcriptase-polymerase chain reaction analysis. Diagn Mol Pathol 10(4):207\u2013213","journal-title":"Diagn Mol Pathol"},{"issue":"6","key":"3671_CR19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/bjh.14153","volume":"174","author":"AM Maeshima","year":"2016","unstructured":"Maeshima AM, Taniguchi H, Toyoda K, Yamauchi N, Makita S, Fukuhara S, Munakata W, Maruyama D, Kobayashi Y, Tobinai K (2016) Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients. Br J Haematol 174(6):923\u2013931. \n                    https:\/\/doi.org\/10.1111\/bjh.14153","journal-title":"Br J Haematol"},{"issue":"5","key":"3671_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","volume":"5","author":"A Rohatiner","year":"1994","unstructured":"Rohatiner A, d\u2019Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M et al (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5(5):397\u2013400","journal-title":"Ann Oncol"},{"issue":"5","key":"3671_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579\u2013586. \n                    https:\/\/doi.org\/10.1200\/jco.2006.09.2403","journal-title":"J Clin Oncol"},{"issue":"13","key":"3671_CR22","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","volume":"121","author":"M Varettoni","year":"2013","unstructured":"Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, Corso A, Orlandi E, Bonfichi M, Gotti M, Pascutto C, Mangiacavalli S, Croci G, Fiaccadori V, Morello L, Guerrera ML, Paulli M, Cazzola M (2013) Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom\u2019s macroglobulinemia and related lymphoid neoplasms. Blood 121(13):2522\u20132528. \n                    https:\/\/doi.org\/10.1182\/blood-2012-09-457101","journal-title":"Blood"},{"issue":"12","key":"3671_CR23","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","volume":"130","author":"C Thieblemont","year":"2017","unstructured":"Thieblemont C, Cascione L, Conconi A, Kiesewetter B, Raderer M, Gaidano G, Martelli M, Laszlo D, Coiffier B, Lopez Guillermo A, Torri V, Cavalli F, Johnson PW, Zucca E (2017) A MALT lymphoma prognostic index. Blood 130(12):1409\u20131417. \n                    https:\/\/doi.org\/10.1182\/blood-2017-03-771915","journal-title":"Blood"},{"issue":"3","key":"3671_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48(3):452\u2013458. \n                    https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"3671_CR25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0002-9440(10)65499-5","volume":"155","author":"A Rosenwald","year":"1999","unstructured":"Rosenwald A, Ott G, Stilgenbauer S, Kalla J, Bredt M, Katzenberger T, Greiner A, Ott MM, Gawin B, Dohner H, Muller-Hermelink HK (1999) Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol 155(6):1817\u20131821. \n                    https:\/\/doi.org\/10.1016\/s0002-9440(10)65499-5","journal-title":"Am J Pathol"},{"issue":"9","key":"3671_CR26","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-04-2282","volume":"11","author":"M Raderer","year":"2005","unstructured":"Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M, Chott A (2005) High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 11(9):3349\u20133352. \n                    https:\/\/doi.org\/10.1158\/1078-0432.ccr-04-2282","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3671_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/cncr.27773","volume":"119","author":"AJ Olszewski","year":"2013","unstructured":"Olszewski AJ, Castillo JJ (2013) Survival of patients with marginal zone lymphoma: analysis of the surveillance, epidemiology, and end results database. Cancer 119(3):629\u2013638. \n                    https:\/\/doi.org\/10.1002\/cncr.27773","journal-title":"Cancer"},{"issue":"1","key":"3671_CR28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/bjh.13178","volume":"169","author":"Y Kamiyama","year":"2015","unstructured":"Kamiyama Y, Kobayashi Y, Fukuhara S, Morikawa N, Munakata W, Miyagi Maeshima A, Maruyama D, Kim SW, Watanabe T, Terauchi T, Muramatsu Y, Tobinai K (2015) Incidental detection of malignant lymphoma in subjects in a cancer surveillance programme. Br J Haematol 169(1):138\u2013142. \n                    https:\/\/doi.org\/10.1111\/bjh.13178","journal-title":"Br J Haematol"},{"issue":"5","key":"3671_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","volume":"31","author":"E Zucca","year":"2013","unstructured":"Zucca E, Conconi A, Laszlo D, Lopez-Guillermo A, Bouabdallah R, Coiffier B, Sebban C, Jardin F, Vitolo U, Morschhauser F, Pileri SA, Copie-Bergman C, Campo E, Jack A, Floriani I, Johnson P, Martelli M, Cavalli F, Martinelli G, Thieblemont C (2013) Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 randomized study. J Clin Oncol 31(5):565\u2013572. \n                    https:\/\/doi.org\/10.1200\/jco.2011.40.6272","journal-title":"J Clin Oncol"},{"issue":"11","key":"3671_CR30","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1093\/annonc\/mdv368","volume":"26","author":"A Conconi","year":"2015","unstructured":"Conconi A, Franceschetti S, Aprile von Hohenstaufen K, Margiotta-Casaluci G, Stathis A, Moccia AA, Bertoni F, Ramponi A, Mazzucchelli L, Cavalli F, Gaidano G, Zucca E (2015) Histologic transformation in marginal zone lymphomasdagger. Ann Oncol 26(11):2329\u20132335. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdv368","journal-title":"Ann Oncol"},{"issue":"21","key":"3671_CR31","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.1158\/1078-0432.CCR-04-0803","volume":"10","author":"S Wohrer","year":"2004","unstructured":"Wohrer S, Streubel B, Bartsch R, Chott A, Raderer M (2004) Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res 10(21):7179\u20137181. \n                    https:\/\/doi.org\/10.1158\/1078-0432.ccr-04-0803","journal-title":"Clin Cancer Res"},{"key":"3671_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1182\/asheducation-2012.1.586","volume":"2012","author":"IM Ghobrial","year":"2012","unstructured":"Ghobrial IM (2012) Are you sure this is Waldenstrom macroglobulinemia? Hematology Am Soc Hematol Educ Program 2012:586\u2013594. \n                    https:\/\/doi.org\/10.1182\/asheducation-2012.1.586","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"3671_CR33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF02983562","volume":"78","author":"Y Kunisaki","year":"2003","unstructured":"Kunisaki Y, Muta T, Yamano Y, Kobayashi Y (2003) Detection of two cell populations corresponding to distinct maturation stages in API-2\/MLT-positive mucosa-associated lymphoid tissue lymphoma cells proliferating in pleural effusion. Int J Hematol 78(4):357\u2013361","journal-title":"Int J Hematol"},{"issue":"9","key":"3671_CR34","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1440-1827.2004.01684.x","volume":"54","author":"T Saito","year":"2004","unstructured":"Saito T, Tamaru J, Kishi H, Kayao J, Kuzuu Y, Wakita H, Adachi A, Itoyama S, Mikata I (2004) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) arising in the small intestine with monoclonal cryoglobulinemia. Pathol Int 54(9):712\u2013718. \n                    https:\/\/doi.org\/10.1111\/j.1440-1827.2004.01684.x","journal-title":"Pathol Int"},{"issue":"2","key":"3671_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3960\/jslrt.48.47","volume":"48","author":"H Ohno","year":"2008","unstructured":"Ohno H, Isoda K (2008) t(11;18)(q21;q21)-positive advanced-stage MALT lymphoma associated with monoclonal gammopathy: resistance to rituximab or rituximab-containing chemotherapy. J Clin Exp Hematop 48(2):47\u201354","journal-title":"J Clin Exp Hematop"},{"key":"3671_CR36","doi-asserted-by":"publisher","first-page":"953297","DOI":"10.1155\/2015\/953297","volume":"2015","author":"R Akoum","year":"2015","unstructured":"Akoum R, Serhal W, Farhat H (2015) Disseminated gastric MALT lymphoma with monoclonal gammopathy, t(11;18)(q21;q21), and subsequent development of T-large granular lymphocytic leukemia: a case report and review of the literature. Case Rep Med 2015:953297. \n                    https:\/\/doi.org\/10.1155\/2015\/953297","journal-title":"Case Rep Med"},{"issue":"9","key":"3671_CR37","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.4049\/jimmunol.171.9.4621","volume":"171","author":"JF Fecteau","year":"2003","unstructured":"Fecteau JF, Neron S (2003) CD40 stimulation of human peripheral B lymphocytes: distinct response from naive and memory cells. J Immunol 171(9):4621\u20134629. \n                    https:\/\/doi.org\/10.4049\/jimmunol.171.9.4621","journal-title":"J Immunol"},{"issue":"3","key":"3671_CR38","doi-asserted-by":"publisher","first-page":"a003350","DOI":"10.1101\/cshperspect.a003350","volume":"2","author":"IE Wertz","year":"2010","unstructured":"Wertz IE, Dixit VM (2010) Signaling to NF-kappaB: regulation by ubiquitination. Cold Spring Harb Perspect Biol 2(3):a003350. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a003350","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1\u20132","key":"3671_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.beha.2016.09.002","volume":"30","author":"MQ Du","year":"2017","unstructured":"Du MQ (2017) MALT lymphoma: genetic abnormalities, immunological stimulation and molecular mechanism. Best Pract Res Clin Haematol 30(1\u20132):13\u201323. \n                    https:\/\/doi.org\/10.1016\/j.beha.2016.09.002","journal-title":"Best Pract Res Clin Haematol"},{"issue":"1","key":"3671_CR40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 229(1):152\u2013172. \n                    https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00782.x","journal-title":"Immunol Rev"},{"issue":"7","key":"3671_CR41","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1182\/blood-2004-06-2297","volume":"105","author":"L Ho","year":"2005","unstructured":"Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P, Staudt LM, Schwaller J (2005) MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 105(7):2891\u20132899. \n                    https:\/\/doi.org\/10.1182\/blood-2004-06-2297","journal-title":"Blood"},{"issue":"5","key":"3671_CR42","doi-asserted-by":"publisher","first-page":"e0127083","DOI":"10.1371\/journal.pone.0127083","volume":"10","author":"JW Yu","year":"2015","unstructured":"Yu JW, Hoffman S, Beal AM, Dykon A, Ringenberg MA, Hughes AC, Dare L, Anderson AD, Finger J, Kasparcova V, Rickard D, Berger SB, Ramanjulu J, Emery JG, Gough PJ, Bertin J, Foley KP (2015) MALT1 protease activity is required for innate and adaptive immune responses. PLoS One 10(5):e0127083. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0127083","journal-title":"PLoS One"},{"issue":"2","key":"3671_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ajh.2830420213","volume":"42","author":"T Murata","year":"1993","unstructured":"Murata T, Fujita H, Harano H, Hukawa M, Kanamori H, Matsuzaki M, Mohri H, Kudoh J, Shimizu N, Okubo T (1993) Triclonal gammopathy (IgA kappa, IgG kappa, and IgM kappa) in a patient with plasmacytoid lymphoma derived from a monoclonal origin. Am J Hematol 42(2):212\u2013216","journal-title":"Am J Hematol"},{"issue":"9","key":"3671_CR44","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1182\/blood-2002-08-2424","volume":"101","author":"J Greeve","year":"2003","unstructured":"Greeve J, Philipsen A, Krause K, Klapper W, Heidorn K, Castle BE, Janda J, Marcu KB, Parwaresch R (2003) Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 101(9):3574\u20133580. \n                    https:\/\/doi.org\/10.1182\/blood-2002-08-2424","journal-title":"Blood"},{"issue":"1405","key":"3671_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1098\/rstb.2000.0751","volume":"356","author":"D Dunn-Walters","year":"2001","unstructured":"Dunn-Walters D, Thiede C, Alpen B, Spencer J (2001) Somatic hypermutation and B-cell lymphoma. Philos Trans R Soc Lond Ser B Biol Sci 356(1405):73\u201382. \n                    https:\/\/doi.org\/10.1098\/rstb.2000.0751","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"3671_CR46","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1182\/blood-2005-09-3613","volume":"107","author":"J Kriangkum","year":"2006","unstructured":"Kriangkum J, Taylor BJ, Strachan E, Mant MJ, Reiman T, Belch AR, Pilarski LM (2006) Impaired class switch recombination (CSR) inWaldenstro\u00a8m macroglobulinemia(WM) despite apparently normal CSR machinery. Blood 107:2920\u20132927. \n                    https:\/\/doi.org\/10.1182\/blood","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-019-03671-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-019-03671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:12:02Z","timestamp":1589627522000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-019-03671-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3671"],"URL":"https:\/\/doi.org\/10.1007\/s00277-019-03671-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"27 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed under the Institutional Review Board approvals from The National Cancer Center Hospital and conducted in accordance with the Declaration of Helsinki. For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}